Cargando…
OR05-06 The Androgen Receptor Is a Tumour Suppressor in Estrogen Receptor Positive Breast Cancer
There is strong interest in targeting the androgen receptor (AR) in estrogen receptor (ER) positive breast cancer, but widespread confusion exits as to what therapeutic strategy - agonism or antagonism - is appropriate. Current understanding of AR predominantly stems from the field of prostate cance...
Autores principales: | Hickey, Theresa E, Selth, Luke, Chia, Kee Ming, Milioli, Heloisa, Roden, Daniel, Laven-Law, Geraldine, Jindal, Shalini, Hui, Mun, Ebrahimie, Esmaeil, birrell, Stephen, Stelloo, Suzan, Caldon, Elizabeth, Findlay-Schultz, Jessica, Abdel_Fatah, Tarek, Ellis, Ian, Zwart, Wilbert, Palmieri, Carlo, Sartorius, Carol Ann, Swarbrick, Alex, Lim, Elgene, Carroll, Jason S, Tilley, Wayne D |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7209210/ http://dx.doi.org/10.1210/jendso/bvaa046.982 |
Ejemplares similares
-
MDM2 inhibition in combination with endocrine therapy and CDK4/6 inhibition for the treatment of ER-positive breast cancer
por: Portman, Neil, et al.
Publicado: (2020) -
Renewed interest in the progesterone receptor in breast cancer
por: Lim, Elgene, et al.
Publicado: (2016) -
Androgen receptor DNA binding and chromatin accessibility profiling in prostate cancer
por: Nevedomskaya, Ekaterina, et al.
Publicado: (2015) -
Androgen receptor profiling predicts prostate cancer outcome
por: Stelloo, Suzan, et al.
Publicado: (2015) -
Rule Discovery in Milk Content towards Mastitis Diagnosis: Dealing with Farm Heterogeneity over Multiple Years through Classification Based on Associations
por: Ebrahimie, Esmaeil, et al.
Publicado: (2021)